BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 12865431)

  • 1. A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition.
    Madi L; Bar-Yehuda S; Barer F; Ardon E; Ochaion A; Fishman P
    J Biol Chem; 2003 Oct; 278(43):42121-30. PubMed ID: 12865431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.
    Fishman P; Madi L; Bar-Yehuda S; Barer F; Del Valle L; Khalili K
    Oncogene; 2002 Jun; 21(25):4060-4. PubMed ID: 12037688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist.
    Fishman P; Bar-Yehuda S; Ardon E; Rath-Wolfson L; Barrer F; Ochaion A; Madi L
    Anticancer Res; 2003; 23(3A):2077-83. PubMed ID: 12894581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A3 adenosine receptor agonist potentiates natural killer cell activity.
    Harish A; Hohana G; Fishman P; Arnon O; Bar-Yehuda S
    Int J Oncol; 2003 Oct; 23(4):1245-9. PubMed ID: 12964011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of synthetic A3 adenosine receptor agonists on cell proliferation and viability are receptor independent at micromolar concentrations.
    Mlejnek P; Dolezel P; Frydrych I
    J Physiol Biochem; 2013 Sep; 69(3):405-17. PubMed ID: 23184730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing pigmentation via activation of A3 adenosine receptors in B16 melanoma cells and in human skin explants.
    Madi L; Rosenberg-Haggen B; Nyska A; Korenstein R
    Exp Dermatol; 2013 Jan; 22(1):74-7. PubMed ID: 23088669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cordycepin (3'-deoxyadenosine) inhibits the growth of B16-BL6 mouse melanoma cells through the stimulation of adenosine A3 receptor followed by glycogen synthase kinase-3beta activation and cyclin D1 suppression.
    Yoshikawa N; Yamada S; Takeuchi C; Kagota S; Shinozuka K; Kunitomo M; Nakamura K
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):591-5. PubMed ID: 18084742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of adenosine A3 receptor inhibits inflammatory cytokine production in colonic mucosa of patients with ulcerative colitis by down-regulating the nuclear factor-kappa B signaling.
    Ren TH; Lv MM; An XM; Leung WK; Seto WK
    J Dig Dis; 2020 Jan; 21(1):38-45. PubMed ID: 31714673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The infarct-sparing effect of IB-MECA against myocardial ischemia/reperfusion injury in mice is mediated by sequential activation of adenosine A3 and A 2A receptors.
    Tian Y; Marshall M; French BA; Linden J; Yang Z
    Basic Res Cardiol; 2015 Mar; 110(2):16. PubMed ID: 25711314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term A3 adenosine receptor activation inhibits the Na+/H+ exchanger NHE3 activity and expression in opossum kidney cells.
    Di Sole F; Cerull R; Babich V; Casavola V; Helmle-Roth C; Burckhardt G
    J Cell Physiol; 2008 Jul; 216(1):221-33. PubMed ID: 18286509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A3 adenosine receptor as a target for cancer therapy.
    Fishman P; Bar-Yehuda S; Madi L; Cohn I
    Anticancer Drugs; 2002 Jun; 13(5):437-43. PubMed ID: 12045454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells.
    Merighi S; Benini A; Mirandola P; Gessi S; Varani K; Leung E; Maclennan S; Borea PA
    J Biol Chem; 2005 May; 280(20):19516-26. PubMed ID: 15774470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis.
    Fishman P; Bar-Yehuda S; Madi L; Rath-Wolfson L; Ochaion A; Cohen S; Baharav E
    Arthritis Res Ther; 2006; 8(1):R33. PubMed ID: 16507132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An adenosine A3 receptor agonist inhibits DSS-induced colitis in mice through modulation of the NF-κB signaling pathway.
    Ren T; Tian T; Feng X; Ye S; Wang H; Wu W; Qiu Y; Yu C; He Y; Zeng J; Cen J; Zhou Y
    Sci Rep; 2015 Mar; 5():9047. PubMed ID: 25762375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression.
    Ochaion A; Bar-Yehuda S; Cohn S; Del Valle L; Perez-Liz G; Madi L; Barer F; Farbstein M; Fishman-Furman S; Reitblat T; Reitblat A; Amital H; Levi Y; Molad Y; Mader R; Tishler M; Langevitz P; Zabutti A; Fishman P
    Arthritis Res Ther; 2006; 8(6):R169. PubMed ID: 17101059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling.
    Lee HS; Chung HJ; Lee HW; Jeong LS; Lee SK
    Immunobiology; 2011 Sep; 216(9):997-1003. PubMed ID: 21514967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IB-MECA, an A3 adenosine receptor agonist prevents bone resorption in rats with adjuvant induced arthritis.
    Rath-Wolfson L; Bar-Yehuda S; Madi L; Ochaion A; Cohen S; Zabutti A; Fishman P
    Clin Exp Rheumatol; 2006; 24(4):400-6. PubMed ID: 16956430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The adenosine A3 receptor agonist Cl-IB-MECA induces cell death through Ca²⁺/ROS-dependent down regulation of ERK and Akt in A172 human glioma cells.
    Kim TH; Kim YK; Woo JS
    Neurochem Res; 2012 Dec; 37(12):2667-77. PubMed ID: 22878643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cl-IB-MECA inhibits human thyroid cancer cell proliferation independently of A3 adenosine receptor activation.
    Morello S; Petrella A; Festa M; Popolo A; Monaco M; Vuttariello E; Chiappetta G; Parente L; Pinto A
    Cancer Biol Ther; 2008 Feb; 7(2):278-84. PubMed ID: 18059189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel adenosine analog, thio-Cl-IB-MECA, induces G0/G1 cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells.
    Lee EJ; Min HY; Chung HJ; Park EJ; Shin DH; Jeong LS; Lee SK
    Biochem Pharmacol; 2005 Sep; 70(6):918-24. PubMed ID: 16051194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.